Skip to main content
Clinical Medicine logoLink to Clinical Medicine
. 2005 May 1;5(3):235–239. doi: 10.7861/clinmedicine.5-3-235

Research governance: panacea or problem?

Ash Samanta 1, Jo Samanta 2
PMCID: PMC4952207  PMID: 16011214

Abstract

Clinical research must meet contemporary professional, legal and ethical standards. Research governance aims to improve quality whilst safeguarding the interests of the public. Research on humans is covered by several internationally recognised ethical codes designed to protect persons from the hazards of experimental treatment. However, to date there is no overarching statutory framework that regulates health and social care research, which is governed by common law principles. The recent European Union Clinical Trials Directive aims to harmonise regulation of clinical trials and protect the interest of study participants. Approval by the new Central Office for Research Ethics Committees (COREC) is now a mandatory requirement for research projects in the UK to ensure stringent ethical standards. Research that involves NHS patients, staff, resources or premises is subject to a framework for research governance that monitors performance and adverse incidents and delineates lines of responsibility and accountability. Researchers at all levels must be fully aware of these new initiatives and of their responsibilities. NHS organisations should acknowledge and commit to clinical research as an intrinsic component of high quality health service delivery.

Key Words: Central Office for Research Ethics Committees (COREC), European Union Clinical Trials Directive, implications for NHS research, MEDICAL RESEARCH, NHS Research, research, research governance

Full Text

The Full Text of this article is available as a PDF (69.4 KB).


Articles from Clinical Medicine are provided here courtesy of Royal College of Physicians

RESOURCES